MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Solution Peptides
153 products · 275 listings
Daily snapshot · inspect sources
Product comparison
Semax Atomized Solution Kit prices
Compare Semax Atomized Solution Kit listings by strength, selection and supplier. Inspect the original source behind each price.
1suppliers represented
2source-linked listings
0strengths available
GO BEYOND THE PRICE
Track it. Plan it. Inspect it.
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Reports and batch records
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Listed amounts and selections
Comparable quantities are not established for these source-defined selections. Inspect the original listing before comparing.
Reported quantities in this family: not established. Counts and units must be matched to the exact listing.
Compare the exact selection
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. 2 listings in this family have incomplete quantity details and receive no inferred per-mg price.
Suppliers with Semax Atomized Solution Kit listings
1 profilesSources and comparison limits
2 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
Explore more selection listings
FROM PEPTIDES CALCULATOR
About Semax
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
Semax is a synthetic seven-residue peptide built at the Institute of Molecular Genetics of the Russian Academy of Sciences by joining the adrenocorticotropic hormone fragment 4-7 to a proline-glycine-proline tail that resists peptidases. It is registered as a medicine only in Russia, in two strengths that are used for quite different purposes: Semax 0.1% nasal drops, an over-the-counter nootropic registered in December 2011 for cognitive and cerebrovascular complaints, and the prescription-only Semax 1% drops registered the same month for the acute period of moderate to severe ischemic stroke. Published work is dominated by Russian-language studies from the group that developed the compound, with rodent evidence that a single dose raises hippocampal BDNF and trkB expression. Outside Russia it is sold as an unapproved research chemical and used as a self-administered nootropic, an application with no clinical support.
- Formula
- C37 H51 N9 O10 S
- Molar mass
- 813.9 g/mol
- CAS number
- 80714-61-0
- Amino acids
- 7
Research evidence described in the source
Small stroke clinical reports
A 1997 study used non-randomized controls and reported faster regression of selected deficits.
Healthy-volunteer imaging
Small controlled fMRI work found changes in resting-state network signals, not clinical outcomes.
BDNF-linked mechanism studies
Rodent studies report changes in neurotrophin expression after Semax.
Limitations noted in the source
- The clinical literature is predominantly Russian and often falls short of modern trial-reporting standards.
- Imaging and biomarker changes do not establish cognitive enhancement or stroke efficacy.
- A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
- Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.
Publications and references linked by the source
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.